Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-10-15
pubmed:abstractText
Pediatric essential thrombocythemia (ET) is a rare and heterogenous disease entity. While several recent studies have focused on the role of the JAK2 V617F mutation in pediatric ET, the frequency of pediatric ET cases with this mutation and the associated clinical features remain unclear.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1545-5017
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
802-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18802948-Adolescent, pubmed-meshheading:18802948-Biological Markers, pubmed-meshheading:18802948-Child, pubmed-meshheading:18802948-Child, Preschool, pubmed-meshheading:18802948-Cohort Studies, pubmed-meshheading:18802948-Exons, pubmed-meshheading:18802948-Female, pubmed-meshheading:18802948-GPI-Linked Proteins, pubmed-meshheading:18802948-Humans, pubmed-meshheading:18802948-Infant, pubmed-meshheading:18802948-Isoantigens, pubmed-meshheading:18802948-Janus Kinase 2, pubmed-meshheading:18802948-Male, pubmed-meshheading:18802948-Membrane Glycoproteins, pubmed-meshheading:18802948-Mutation, pubmed-meshheading:18802948-Neutrophils, pubmed-meshheading:18802948-Polymerase Chain Reaction, pubmed-meshheading:18802948-Receptors, Cell Surface, pubmed-meshheading:18802948-Thrombocythemia, Essential
pubmed:year
2008
pubmed:articleTitle
Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.
pubmed:affiliation
Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
pubmed:publicationType
Journal Article